Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Bayer Norway AS
AS
Active
Org 998720516
Drammensveien 288, 0283
Oslo
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2012 · 13 years old
9 employees
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Bayer Norway AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
2M
2M
1M
1M
0M
2021: 2M
2M
2021
2022: 2M (0% vs 2021)
2M
0%
2022
2023: 2M (0% vs 2022)
2M
0%
2023
2024: 2M (0% vs 2023)
2M
0%
2024
2025: 2M (0% vs 2024)
2M
0%
2025
EBITDA
NOK millions
0M
0M
-1M
-1M
-1M
2021: -1M
-1M
2021
2022: 0M (+100% vs 2021)
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
1 712
1 763
1 853
1 942
1 667
Staff expenses
−0
−1 338
−1 332
−1 629
−1 692
EBITDA
−382
−285
−100
−371
−654
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−382
−285
−100
−371
−654
Net financials
43 399
11 576
39 809
−1 041 051
−11 195
Profit before tax
43 017
11 291
39 709
−1 041 423
−11 849
Tax
−0
−22 230
7 046
−6 770
8 972
Net profit
33 419
33 521
32 663
−1 034 652
−20 821
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
1 099 692
1 068 043
1 071 066
1 073 109
2 050 736
Equity
687 672
654 254
478 733
61 070
1 045 730
Long-term debt
401 000
406 000
585 000
997 500
995 000
Short-term debt
11 020
7 789
7 334
14 539
10 007
Total debt
412 020
413 789
592 334
1 012 039
1 005 007
Financial ratios
5-year trend
EBITDA margin
−22,3 %
This company
15,8 %
Market median
This company
Market median
241% below market
2021
2025
Equity ratio
62,5 %
This company
38,2 %
Market median
This company
Market median
64% above market
2021
2025
Return on equity
4,9 %
This company
18,4 %
Market median
This company
Market median
73% below market
2021
2025
Net profit margin
>999 %
This company
8,1 %
Market median
This company
Market median
>999% above market
2021
2025
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2021
2025
Debt / equity
0,60×
This company
0,62×
Market median
This company
Market median
3% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on Bayer Norway AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
